DE602007010926D1 - Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol - Google Patents

Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol

Info

Publication number
DE602007010926D1
DE602007010926D1 DE602007010926T DE602007010926T DE602007010926D1 DE 602007010926 D1 DE602007010926 D1 DE 602007010926D1 DE 602007010926 T DE602007010926 T DE 602007010926T DE 602007010926 T DE602007010926 T DE 602007010926T DE 602007010926 D1 DE602007010926 D1 DE 602007010926D1
Authority
DE
Germany
Prior art keywords
esomeprazole
production
ammonium salts
new method
ammoniumsalts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007010926T
Other languages
English (en)
Inventor
Rolf Bergman
Christina Fregler
Per Lindberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE602007010926D1 publication Critical patent/DE602007010926D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE602007010926T 2006-06-07 2007-06-07 Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol Active DE602007010926D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81169806P 2006-06-07 2006-06-07
PCT/SE2007/000548 WO2007142580A1 (en) 2006-06-07 2007-06-07 Novel method for preparation of ammonium salts of esomeprazole

Publications (1)

Publication Number Publication Date
DE602007010926D1 true DE602007010926D1 (de) 2011-01-13

Family

ID=38801724

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007010926T Active DE602007010926D1 (de) 2006-06-07 2007-06-07 Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol

Country Status (10)

Country Link
US (1) US20090197919A1 (de)
EP (1) EP2029574B1 (de)
JP (1) JP2009539830A (de)
CN (1) CN101460481A (de)
AT (1) ATE490247T1 (de)
CA (1) CA2653429A1 (de)
DE (1) DE602007010926D1 (de)
ES (1) ES2355164T3 (de)
HK (1) HK1128462A1 (de)
WO (1) WO2007142580A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
CN102440965B (zh) * 2010-10-13 2013-04-10 江苏奥赛康药业股份有限公司 一种供注射用的埃索美拉唑钠组合物及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
DK1487818T3 (da) * 2002-03-05 2007-08-20 Astrazeneca Ab Alkylammoniumsalte af omeprazol og esomeprazol
WO2004037253A1 (en) * 2002-10-22 2004-05-06 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
SE0302381D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
SE0302382D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts II

Also Published As

Publication number Publication date
EP2029574A1 (de) 2009-03-04
WO2007142580A1 (en) 2007-12-13
ES2355164T3 (es) 2011-03-23
US20090197919A1 (en) 2009-08-06
EP2029574B1 (de) 2010-12-01
HK1128462A1 (en) 2009-10-30
JP2009539830A (ja) 2009-11-19
ATE490247T1 (de) 2010-12-15
CN101460481A (zh) 2009-06-17
CA2653429A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
EA201100727A1 (ru) Новый способ получения производных аминокислот
EA200702329A1 (ru) Замещенные пирролпиридины, содержащие их композиции, способ получения и применение
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
AT516600A5 (de) Herstellung von faktor h (fh) und fh-derivaten aus plasma
EA201270520A1 (ru) Новые соединения, эффективные в качестве ингибиторов ксантиноксидазы, способ их получения и содержащая их фармацевтическая композиция
TW200630336A (en) Novel compounds
SE0301009D0 (sv) Novel compounds
TW200621690A (en) Novel compounds
ATE528305T1 (de) Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz
EA201892050A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
EA200900397A1 (ru) Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
ATE507230T1 (de) Neues stereospezifisches verfahren zur herstellung von dioxabicyclooctan-verbindungen
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
DE602007010926D1 (de) Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol
DE602006017671D1 (de) Verfahren zur herstellung von tricarbonsäuretris(alkylsubstituiertes cyclohexylamid)
ATE466010T1 (de) Verfahren zur herstellung von candesartan
EA201390327A1 (ru) Гетероциклильные соединения в качестве лигандов гистаминовых hрецепторов
ATE538098T1 (de) Verfahren zum herstellen von 5-fluor-1,3-dialkyl- 1h-pyrazol-4-carbonsäurechloriden
ATE528312T1 (de) Verfahren zur synthese von makroliden